News Focus
News Focus
Followers 1353
Posts 273325
Boards Moderated 55
Alias Born 12/07/2009

Re: None

Friday, 06/27/2025 7:59:45 AM

Friday, June 27, 2025 7:59:45 AM

Post# of 159
$CVKD Significant unmet need & market opportunity for Tecarfarin ($2B annually)

•Collab with Abbott $ABT for Phase 3 trials

•FDA granted Orphan Drug designation for Tecarfarin and FDA Fast Track Designation

•Clear Regulatory Pathway with No Development Competition #biotech #FDA

Bullish
Bullish

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVKD News